squaric acid dibutyl ester has been researched along with Epidermodysplasia Verruciformis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erickson, C; Gaspari, AA; Kehdy, J; Rady, P; Tyring, S | 1 |
| Ibe, M; Ishiji, T; Kawase, M; Niimura, M | 1 |
2 other study(ies) available for squaric acid dibutyl ester and Epidermodysplasia Verruciformis
| Article | Year |
|---|---|
Epidermodysplasia verruciformis: successful treatment with squaric acid dibutylester.
Topics: Adjuvants, Immunologic; Adult; Cyclobutanes; Epidermodysplasia Verruciformis; Female; Humans; Immunotherapy; Treatment Outcome | 2015 |
Patients with epidermodysplasia verruciformis show no response to contact immunotherapy.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Cyclobutanes; Dinitrochlorobenzene; DNA, Viral; Epidermodysplasia Verruciformis; Female; Humans; Immunotherapy; Male; Papillomaviridae; Papillomavirus Infections; Skin; Treatment Outcome; Tumor Virus Infections | 2001 |